Tue, Mar
44 New Articles

Kinstellar Advises X-Chem on Acquisition of ComInnex

Kinstellar Advises X-Chem on Acquisition of ComInnex

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Kinstellar has advised US-based X-Chem on its acquisition of Hungary's ComInnex.

X-Chem provides pharmaceutical and biotech companies with solutions for screening, hit validation, and lead optimization. The company leverages its DNA-encoded chemical library (DEL) platform to discover novel small molecule leads against therapeutic targets.

ComInnex is a chemistry service organization, supporting early-stage drug discovery through its products and services. The company has over 20 years of experience in offering custom chemistry, chemical library development and synthesis, project management, and customer service.

"As a united company, with an increased global presence, we are positioned to meet the increasing demand for innovative chemistry solutions and high-quality discovery services worldwide," X-Chem CEO Matt Clark commented. "The acquisition of ComInnex further extends X-Chem’s expertise and scale of DEL services to help biopharma clients of any size efficiently unlock exponential possibilities in small molecule drug discovery."

"Combining X-Chem, the world leader and pioneer of high-quality DEL technology, and ComInnex, a leader in the most important trends and novel approaches in early-stage drug discovery chemistry, will yield a powerhouse partner for innovative drug discovery solutions," added ComInnex CEO Alex Drijver.

The Kinstellar team was led by Partner Anthony O’Connor and included Managing Associate Agnes Zsofia Szabo, Senior Associate Eszter Takacsi-Nagy, and Junior Associates Bertalan Vanya and Judit Sos.

Editor's Note: After this article was published, CEE Legal Matters learned that Jalsovszky advised the sellers on the transaction. The firm's team included Managing Partner Pal Jalsovszky and Senior Attorneys Peter Gyimesi and Agnes Bejo.


Hungary Knowledge Partner

Nagy és Trócsányi was founded in 1991, turned into limited professional partnership (in Hungarian: ügyvédi iroda) in 1992, with the aim of offering sophisticated legal services. The firm continues to seek excellence in a comprehensive and modern practice, which spans international commercial and business law. 

The firm’s lawyers provide clients with advice and representation in an active, thoughtful and ethical manner, with a real understanding of clients‘ business needs and the markets in which they operate.

The firm is one of the largest home-grown independent law firms in Hungary. Currently Nagy és Trócsányi has 26 lawyers out of which there are 8 active partners. All partners are equity partners.

Nagy és Trócsányi is a legal entity and registered with the Budapest Bar Association. All lawyers of the Budapest office are either members of, or registered as clerks with, the Budapest Bar Association. Several of the firm’s lawyers are admitted attorneys or registered as legal consultants in New York.

The firm advises a broad range of clients, including numerous multinational corporations. 

Our activity focuses on the following practice areas: M&A, company law, litigation and dispute resolution, real estate law, banking and finance, project financing, insolvency and restructuring, venture capital investment, taxation, competition, utilities, energy, media and telecommunication.

Nagy és Trócsányi is the exclusive member firm in Hungary for Lex Mundi – the world’s leading network of independent law firms with in-depth experience in 100+countries worldwide.

The firm advises a broad range of clients, including numerous multinational corporations. Among our key clients are: OTP Bank, Sberbank, Erste Bank, Scania, KS ORKA, Mannvit, DAF Trucks, Booking.com, Museum of Fine Arts of Budapest, Hungarian Post Pte Ltd, Hiventures, Strabag, CPI Hungary, Givaudan, Marks & Spencer, CBA.

Firm's website.

Our Latest Issue